China SXT Pharmaceuticals, Inc. (SXTC)
Nasdaq: SXTC · Pharmaceutical Preparations · Taizhou · filing with the SEC since 2017
Who runs China SXT Pharmaceuticals, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Simon Lim Sze Beng
Co-Chief Executive Officer. First filing Apr 2026, latest Apr 27, 2026, 0 filings in all.
Officers reporting now
3
of 7 people with a filing in the last fifteen months
Directors reporting now
4
7 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Simon Lim Sze Beng | Co-Chief Executive Officer | Apr 2026 | Apr 27, 2026 | none |
| Zhou Feng Felix | Co-CEO and Director | Apr 2026 | Apr 27, 2026 | none |
| Pan Xiaodong Sean | Chief Financial Officer | Apr 2026 | Apr 27, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Chee Yong Lip | director | Apr 2026 | Apr 27, 2026 | none |
| Ji Xiaodong | director | Apr 2026 | Apr 27, 2026 | none |
| Liu Tong Tony | director | Apr 2026 | Apr 27, 2026 | none |
| Zheng Jun | director | Apr 2026 | Apr 27, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.